Citius Pharmaceuticals logo

Citius Pharmaceuticals

CTXR | NASDAQ
Chart Builder DCF Calculator
$0.54
$0.00 (+0.92%)
At close: Nov 16, 2026, 3:59 PM ET
$0.53
-$0.01 (-1.87%)
After-hours: Nov 16, 2026, 7:53 PM ET
+0.92%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
47
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #346/1021 (Top 34%)

Key Statistics

Market Data

Market Cap $14.81M
1D Range
0.50 0.55
52W Range
0.37 1.44

Valuation (TTM)

PE -0.26
PB 0.22
EV/EBITDA -0.09

Valuation (NTM)

Forward PE 0.65
Forward PEG 0.01
Price Target $6.00
Loading financial charts...

Profile

Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed tow...

Sector Healthcare
Industry Biotechnology
Employees 23
IPO Date Oct 2, 2014
Fiscal Year October - September

Latest News

No news articles available yet.

Earnings

Next Earnings
Dec 22, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$6.00
Upside
+1011.11%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.